Furthermore, an experimental study by Wang et al. has shown interesting results where 3-deoxyglucosone (3DG), a precursor for advanced glycation end-products known to be able to induce glucose intolerance, reduces GLP-1 release [46]. The gene discussed is GCG; the disease is Glucose intolerance.